Cargando…
Molecular Targeted Therapies of Aggressive Thyroid Cancer
Differentiated thyroid carcinomas (DTCs) that arise from follicular cells account >90% of thyroid cancer (TC) [papillary thyroid cancer (PTC) 90%, follicular thyroid cancer (FTC) 10%], while medullary thyroid cancer (MTC) accounts <5%. Complete total thyroidectomy is the treatment of choice fo...
Autores principales: | Ferrari, Silvia Martina, Fallahi, Poupak, Politti, Ugo, Materazzi, Gabriele, Baldini, Enke, Ulisse, Salvatore, Miccoli, Paolo, Antonelli, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653714/ https://www.ncbi.nlm.nih.gov/pubmed/26635725 http://dx.doi.org/10.3389/fendo.2015.00176 |
Ejemplares similares
-
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration
por: Ferrari, Silvia Martina, et al.
Publicado: (2018) -
Environmental Issues in Thyroid Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2017) -
Selective use of vandetanib in the treatment of thyroid cancer
por: Fallahi, Poupak, et al.
Publicado: (2015) -
New Therapies for Dedifferentiated Papillary Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2015) -
MON-565 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With Oral Liquid L-thyroxine (L-T4) Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019)